Hoxworth Issues Emergency Appeal for Blood and Platelet Donors
CincinnatiHoxworth Blood Center has issued an emergency appeal for donors of all blood types, especially Type O, and platelet donors.
As of this morning, the communitys blood supply was down 378 units in type O+ and O- combined, which are the types in greatest demand at local hospitals (one unit equals one pint).
Reasons for the shortage include inclement weather resulting in below average collections and flu and other seasonal illnesses which have caused high deferral rates. Heavy usage at local hospitals is a contributing factor as well.
Hospitals and trauma centers can't function without Type O blood, the most common blood type. Approximately 44 percent of the population is either O+ or O- (38% O+ and 6% O-).
Inventory levels are dropping dramatically as demand for blood products has risen over the past week, says Ronald Sacher, MD,. director of Hoxworth. Were asking all individuals to donate at their earliest convenience as this situation is very serious.
You are urged to donate at one of Hoxworths nine neighborhood donor centers in
In times of shortages, walk-ins are always welcome or you can schedule an appointment by calling (513) 451-0910 or (800) 830-1091.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.